{"id":205225,"name":"NOVARTIS, INC.","slug":"novartis-inc","state":"DC","country":"United States of America","description":"&#226;€‹Multinational biopharmaceutical company.","totalSpending":1680000,"filings":29,"yearlySpending":[{"year":2020,"income":190000},{"year":2021,"income":200000},{"year":2022,"income":650000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":240000}],"issues":["PHA","HCR","MMM","TAR","TRD"],"firms":["TODD STRATEGY GROUP"],"lobbyists":["DANIEL TODD","PAUL EDATTEL","TAYLOR SEXTON","JEFF LUCAS","NICHOLAS UEHLECKE","ERIC BERGREN","KATHERINE COTTON","TED LEHMAN","KIMBERLY LINTHICUM"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Drug Pricing\nCOVID-19 Response.","COVID-19 Response.","Drug Pricing.","COVID-19 Response.","Drug Pricing.\nSupply Chain."],"years":[2020,2021,2022,2023,2024,2025]}